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Challenges of Phage Therapy as 
a Strategic Tool for the Control 
of Salmonella Kentucky and 




Salmonella Kentucky ST198 (S. Kentucky ST198) is the most ubiquitous 
 multidrug resistant (MDR) strain posing the greatest threat to public health, 
livestock and food industry in Africa. The reinvention of bacteriophage (Phage) 
as a non-antibiotic alternative only gives a glimmer of hope in the control of MDR 
strains of Salmonellae. S. Kentucky ST198 posses’ chromosomal and plasmid factors 
capable of been co-opted into phage mediated transduction and co-transduction 
of antibiotic resistance genes (ARGs) as well as cross-serovar transduction of 
ARGs. Phage DT104, DT120 and P-22 like prophages like PDT17 and ES18 together 
have been shown to be capable of transducing and co-transducing the classical 
ACSSuT resistance phenotype identified in most S. Kentucky ST198 strain on the 
continent. Also, the institution of fluoroquinolones and third generation cepha-
losporin for salmonellosis treatment in animals or human infected by S. Kentucky 
ST198 strain resistant to these drugs can induce Salmonella phage transduction of 
kanamycin between different Salmonella serovars if present. This review highlights 
 possible risk associated with the use of known Salmonella phages in the control of 
S. Kentucky ST198 and the need for chromosomal and plasmid tracking of genes 
prior to the institution of phage therapy on the continent.
Keywords: Bacteriophages, Salmonella Kentucky ST198, DT104, transduction, ARGs, 
Salmonella conjugative plasmids, Africa
1. Introduction
Bacteriophages (here in after called phages are viruses that can infect a bacteria 
and replicate within it) are completely alien to the routine therapeutic regimens in 
both veterinary and human medical practices in Africa, and where phage therapies 
have been instituted they are mainly experimental. Phage therapy has shown to 
be an ecologically sustainable tool in the control of bacterial infection; scientific 
researches places phages to be superiorly bactericidal specific, efficacious and 
cost effective when compared to antibiotics and interestingly it has been proven to 
inhibit biofilm formation in pathogenic bacteria [1–3], customarily the production 
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of biofilms by bacterial cells significantly increases their resistance to  antimicrobials 
as compared to what is normally seen by the same cells being planktonic [4]. In 
Africa, the indiscriminate use of antimicrobials for treatment of salmonellosis in 
both human medical and veterinary practices has allowed for the proliferation of 
multidrug resistant (MDR) determinants and the sharing of antibiotic resistant 
genes (ARGs) between serovars of Salmonellae and other bacteria population, and 
on a continent where Poverty, human immunodeficiency virus/acquired immune 
deficiency syndrome (HIV/AIDS), Malaria, Tuberculosis and other immuno-
compromising diseases are prevalent, the impact of MDR salmonellosis is severe 
[5]. It has become pertinent that alternative strategies for control of salmonellosis 
and Salmonella associated infections be adopted especially where MDR strains 
of Salmonellae persist. Salmonella Kentucky (S. Kentucky) is amongst the most 
ubiquitous Salmonella serovar identified on the African continent in the present 
decade and MDR strains pose significant health risk and a threat to the livestock 
production, livestock trade and food industry [5]. Several MDR strains have been 
isolated in most regions of the continent and the abusive use of antibiotics has only 
enhanced its mutative MDR tendencies and acquisition of ARGs between serovars 
and other non-genera of Salmonella. The institution of phages in the treatment of 
salmonellosis has shown promising results because of their very low transduction 
frequencies in the transmission of ARGs of Salmonella spp. [6], they exist every-
where in the environment and are natural, economically sustainable, nontoxic 
and some phages have shown broad activity against numerous serovars of MDR 
Salmonella spp. [7, 8]. Felix-O1 and SE13 are examples of Salmonella phages with 
broad serovar capacities; Felix-O1, a virulent phage was proven to infect 98.2% of 
all Salmonella strain and SE13 was capable of lysing 83.6% of Salmonella strain it 
was tested with [7, 8]. While researches on the use of phages for the treatments of 
S. Kentucky in Africa are scarce, [9] reported an effective use of phage in the reduc-
tion of S. Kentucky colonization in different broiler farms in Egypt. Phage–host 
interactions through the mechanism of horizontal gene transfer have contributed 
significantly to genetic flux vastly responsible for the acquisition and dissemination 
of important bacterial phenotypes, such as enhanced colonization of the human or 
animal gut epithelium, AMR and toxin production [10, 11]. Thus, the identification 
and careful selection of phages devoid of genetic elements that could pose risk to 
human and animal health is critical to biocontrol applications [12]. This review 
proposes to highlight challenges that may arise in the institution of phages as a 
strategic non-antibiotic tool for the control S. Kentucky and repertoire of its ARGs 
without prior studies on their genetic make-up.
2. Antibiotic resistant gene
Antibiotic resistance genes (ARGs) are an emerging public health contaminant, 
posing a potential global health risk. A major factor contributing to the increased 
environmental burden of ARGs is the rise in intensive livestock farming [13]. The 
World Health Organization (WHO) defines antimicrobial resistance (AMR) as “an 
increase in the minimum inhibitory concentration of a compound for a previously 
sensitive strain” [14]. Human beings consistently use large amounts of antibiotic 
in the human medical contexts as well as for growth factors and prophylaxis in 
agriculture and livestock, culminating in the contamination of environmental 
microbial communities. Unfortunately, even when pathogenic bacteria are the 
specific targets of antibiotic use, hundreds of non-pathogenic bacteria species are 
affected [15]. Thus, antibiotics are present in microbial communities, not only as 
a result of the natural lifecycle of microorganisms but also to the usage of these 
3
Challenges of Phage Therapy as a Strategic Tool for the Control of Salmonella Kentucky…
DOI: http://dx.doi.org/10.5772/intechopen.95329
drugs in agriculture, food industry, livestock and human health [16]. The  presence 
of antibiotic resistance genes in environmental bacteria may be responsible for 
different mechanisms employed to overcome the natural antibiotics present in 
the environment. Recently this gene pool has been named the ‘resistome’, and its 
components can be mobilized into the microbial community affecting humans 
because of the participation of genetic platforms that efficiently facilitate the mobi-
lization, transmission and maintenance of these resistance genes. Evidence for this 
transference has been suggested and or demonstrated using cutting-edge research 
techniques with newly identified widespread genes in multidrug-resistant bacteria 
[17]. These resistance genes include those responsible for plasmid-mediated efflux 
pumps conferring low-level fluoroquinolone resistance (qepA), ribosomal meth-
ylases affecting aminoglycosides (armA, rtmB) and methyltransferases affecting 
linezolid (cfr) all of which have been associated with antibiotic-producing bacteria. 
Recently, resistance genes whose ancestors have been identified in environmental 
isolates that are not recognized as antibiotic producers have also been detected. 
These include the qnr and the blaCTX genes compromising the activity of fluoro-
quinolones and extended-spectrum cephalosporins, respectively [17]. Bacteria can 
express antibiotic resistance through chromosomal mutations or via the acquisi-
tion of genetic material through horizontal gene transfer from other bacteria or 
the environment. Acquisition of genetic material via horizontal gene transfer is 
largely driven by mobile genetic elements (MGEs), such as plasmids, transposons or 
bacteriophages, which play a critical role in the evolution and ecology of bacterial 
communities by controlling the intra-species and interspecies exchange of genetic 
information [18]. While the transfer of these MGEs usually occur through transfor-
mation, transduction, or conjugation, conjugation is mostly considered the most 
efficient mechanism employed for the exchange of genetic material among bacteria 
[19]. The ease of acquisition and spread of ARGs by bacteria via conjugation is 
frequently through conjugative plasmids and transposons, and the contribution of 
these elements to antibiotic resistance pool has been extensively studied in hospital, 
community, agricultural and environmental settings [15–17, 20, 21], but very little 
is known about the role of bacteriophages as vehicles for ARGs in environmental 
settings. Recent findings based on cutting-edge genomic technologies suggest that, 
in these settings, bacteriophages play a more important role in the mobilization of 
ARGs than previously documented [22].
3. Phage transduction: primary mechanism for the transfer of ARGs
Intensive studies of the mechanisms for horizontal gene transfer responsible for 
the increased spread of antibiotic resistance to foodborne bacterial pathogens have 
been undertaken; Conjugation, transformation, and transduction are the funda-
mental mechanisms by which dissemination of ARGs occurs [23]. Transduction is 
primarily the horizontal gene transfer mechanisms employed by most phages, and 
recent findings have shown phage-mediated transduction to be a significant driver 
in the dissemination of ARGs [24]. The concept that phage mediated transduction is 
a major driver of horizontal transfer of ARGs between foodborne pathogens, as well 
as from the environment to animals and humans, is increasingly been recognized. 
Phages are recognized as the most abundant organism in the biosphere, and are 
found in every environment regardless of their diversities, including oceans, lakes, 
soil, urban sewage, potable and well water, plant and animal microbial communities 
[25]. ARGs are often found on various MGEs, and are readily transferred horizon-
tally by phage transduction [24]. Phages infect bacteria and either incorporate their 
viral genome into the host genome, replicating as part of the host (lysogenic cycle), 
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or replicate inside the host cell before releasing new phage particles (lytic cycle) 
[22, 26]. Phages can be either virulent or temperate. The mechanism of transduc-
tion has been vastly described in virulent phages (defined by their capacity to 
undergo lytic cycles). Following bacterial infection, there is an immediate induc-
tion of phage particles formation and lysis of the host cell but virulent phages do 
not integrate their DNA into the host chromosome. Temperate phages (known to 
undergo lysogenic cycle), integrate their DNA into the host chromosome and the 
prophage may remain dormant in the host until other factors like stress induces 
the excision of the phage from the chromosome leading to subsequent formation 
of phage particles and lysis of the host cell. Some phages can also adopt a pseu-
dolysogenic state under unfavourable growth condition. In this state, their genome 
does not degrade but rather exist within the host cytoplasm as a plasmid and 
during bacterial cell division becomes incorporated into just one daughter cell [26]. 
Genetic materials are transferred between hosts either by generalized or specialized 
transduction. Virulent and temperate phages can undergo generalized transduc-
tion, here, bacterial DNA fragments are randomly packaged into the phage capsid 
during their lytic cycle forming a “transducing particle”. These “offspring” phages 
do not contain phage genes, and only the capsid has a viral origin. Despite this, the 
transducing particle is capable of injecting the bacterial genes into a susceptible 
recipient cell, which can subsequently be incorporated into the host genome by 
recombination [5, 22, 24]. Specialized transduction is restrictive to temperate 
phages and results in the packaging of bacterial DNA into phages at a higher 
frequency; temperate phages insert their genomes into a specific region of the host 
chromosome. An inaccurate excision of the prophage may lead to the capture of the 
flanking genes adjacent to the phage integration point. If capsids carrying the rear-
ranged phage genome with these foreign genes infect other bacteria and integrate 
into the host chromosome, transduction of the acquired genes will be achieved. 
However, the probability that the transferred genes are antibiotic resistance-related 
is relatively low [5].
4. Phage transduction of ARGs in Salmonellae
Salmonella phages have been extensively used in molecular biology for the 
introduction of foreign genes by generalized and specialized transduction. P-22, a 
well-known phage is a classical example, other P-22 like prophages ST104 or PDT17, 
harboured within DT104 phage type have been hypothesized to facilitate horizontal 
transfer of the penta-resistance genes [27, 28]. The penta-resistance genes in phage 
type DT104 are clustered on a 43-kb Salmonella genomic island-1 (SGI1), which 
is flanked by two type I integrons [29]. Salmonella genomic island 1 (SGI1) is an 
integrative mobilizable element that harbours a multidrug resistance (MDR) gene 
cluster. A research undertaken by [27] asserted that ES18 and PDT17, also a P-22 like 
phage, following release from DT104 could transduce ARGs. Their findings further 
demonstrated the transduction of cam and amp by phage PDT17 and amp, cam, 
and tet, which confer resistance to ampicillin, chloramphenicol, and tetracycline, 
respectively, by ES18 from a donor DT104 strain into a DT104 recipient strain lack-
ing these resistance genes. Phage ES18 also co-transduces selected ARGs of the 71 tet 
transductants and of the 145 cam transductants. Interestingly, in 14 of 16 transduc-
tants, it was noticed that phage E18 could co- transduce sul and str, genes involved 
in resistance to sulphonamides and streptomycin, respectively, together with amp, 
cam, and tet to create the ACSSuT (ampicillin, chloramphenicol, streptomycin, 
sulphonamides, and tetracycline) resistance phenotype [27]. This co-transduction 
likely occurs because amp and str are situated on the integrons flanking SGI1, and 
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the phage likely packages the SGI1 and its flanking integrons [30–32]. P-22 phage 
has also been identified within DT120 isolates shown to be capable of generalized 
transduction and possess the ACSSuT resistant strain [33]. See [33] reported that 
carbadox, a veterinary antibacterial that posses’ mutagenic and carcinogenic capa-
bilities induced phage transduction in DT104 and DT120. Furthermore the absence 
of transduction in DT104 strain which had its P-22 like prophage deleted following 
induction with carbadox suggests that P-22 like prophages are responsible for gener-
alized transduction. Thus; transduction and co-transduction by P22-like prophages 
of ARGs co-located within SGI1 in multidrug-resistant Salmonellae strains is a 
common phenomenon. Also, genome scanning proved that P22-like prophages were 
common in 18 Salmonella serovars implying that generalized transduction may be 
greatly underestimated [33].
5. Transduction of Ciprofloxacin and cephalosporins genes
Ciprofloxacin a fluoroquinolone and third generation cephalosporin are 
the drugs of choice in the treatment of invasive Salmonella infections [34–36]. 
Resistance of Salmonella to ciprofloxacin is due mainly to double mutations in gyrA 
and a single mutation in parC genes. In addition, oqxAB operon is suggested to be 
responsible for the increase in resistance observed in clinical Salmonella strains [37]. 
It was observed by [38], that Ciprofloxacin, enrofloxacin and danofloxacin induced 
Salmonella phage DT104 and DT102 transfer of a native kanamycin resistance plas-
mid to a strain of Salmonella Typhimurium by generalized transduction. Resistance 
to cephalosporin is mainly due to extended spectrum beta-lactamases (ESBLs), such 
as TEM-, SHV-, and CTX-M, or plasmid mediated AmpC β-lactamases (pAmpCs), 
such as CMY, encoded on transmissible conjugative plasmids [39–41], or be 
transferred by generalized transduction. Phage P24, induced from an isolate of S. 
Typhimurium, was propagated on a multidrug resistant strain of S. Heidelberg (S25). 
Thus, when the MDR S25 harbouring phage P24 was used as transduction donor 
to transfer ESBL and tetracycline resistance genes to a recipient S. Typhimurium 
isolate. PCR confirmed the presence of blaCMY-2, tet(A), and tet(B) in vari-
ous S. Typhimurium transductants. Although the tetracycline genes were not 
 co-transduced with blaCMY-2, their transduction frequency was equivalent, indi-
cating generalized transduction and evidently reporting the transfer of ARGs by 
phage-mediated transduction between different Salmonella serovars. This finding 
likely expresses that cross-serovar transduction occurs frequently because phages 
can bind to various surface protein receptors on different species and serovars [42]. 
The LPS, FliC, OmpC, OmpF, OmpA, are examples of phage receptors present in 
Salmonella [43]. In the previous study [42] it was observed that 13 inducible phages 
recovered from 31 Salmonella serovars were capable of propagating on two or more 
Salmonella serovars including those often responsible for foodborne outbreaks such 
as S. Heidelberg, S. Enteritidis, S. Typhimurium and S. Kentucky. Finally, the findings 
of [42] demonstrate the spread of antibiotic resistance in Salmonellae by phage 
mediated transduction.
6. Transduction of R-factor genes
R-factors which are a group of conjugative plasmids that harbour one or more 
antibiotic resistance determinants and represents another form of MGE that can 
be transferred horizontally by phage mediated transduction [24]. Conjugative 
plasmids are also self-transmissible, affording them the capacities to increase the 
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spread of ARGs. The origin of transfer (oriT), MOB genes, and the mate-pair 
formation (MPF) genes are the essential components for conjugation [44, 45]. In 
order for conjugation to occur, a protein complex called a ‘relaxasome’ responsible 
for processing plasmid DNA to prepare it for transfer must form at the oriT [46–48] 
and the mechanism for R-factor-phage acquisition and propagation of ARGs may be 
random. R factors in close proximity to P22-like prophages could be integrated into 
the head of the assembling phage during induction from its host, thus contributing 
to the spread of ARGs within bacteria capable of causing foodborne illnesses, in the 
intestinal flora of livestock and in the environment [24].
7.  Virulent factors of S. Kentucky ST198 that may potentiate  
phage-mediated transduction of ARGs
Salmonella Kentucky ST198 is a global contaminant and an emerging risk for 
foodborne illness, although first identified in Egypt it has now been isolated in 
several countries across the different regions in Africa [5, 49], with reservoirs in 
various animals and food [49–54]. Successes have been recorded with the institu-
tion of phages in controlling the spread of MDR Salmonella Kentucky [9, 55]; these 
findings however rarely discuss the tendencies of phage-host mediated propagation 
of ARGs or other MDR determinants. S. Kentucky ST198 belongs to a single lineage, 
which is predicted to emerged circa 1989 following the acquisition of the AMR-
associated Salmonella genomic island (SGI) 1 (variant SGI1-K), that confers resis-
tance to ampicillin, streptomycin, gentamicin, sulfamethoxazole and tetracycline 
[56]. This MDR Salmonella Kentucky clone has undergone substitution mutations 
in the quinolone-resistance-determining regions (QRDRs) of DNA gyrase (gyrA) 
and DNA topoisomerase IV (parC) genes, such that most strains carry three QRDR 
mutations which together confer resistance to ciprofloxacin. Its molecular charac-
terization further shows a chromosomal genomic island carrying resistance genes 
that confer resistance to β-lactam antibiotics, carbapenems, quinolones, aminogly-
cosides, co-trimoxazole (trimethoprim-sulfamethoxazole), and to Azithromycin. 
Extended-spectrum cephalosporins (ESCs) resistance has also been associated with 
S. Kentucky ST198 [57–60]. Genetic basis for this resistance showed an extended-
spectrum b-lactamase (ESBL) [61]. The aforementioned resistant properties 
evidently can allow for the transfer of native kanamycin resistance plasmid to 
strains of S. Typhimurium or other Salmonella serovar by generalized transduction 
as treatment with these antibiotics as reported by [38] can induce Salmonella phage 
DT104 and DT102 transmission of a native kanamycin resistance plasmid and other 
ARGs between serovars of Salmonella by generalized transduction. S. Kentucky also 
exhibits an extensive MDR pattern with diverse resistance profile cutting across 
human, environmental and poultry micro biomes [57]. A penta-resistant profile 
(SSuTCipNa) was observed in S. Kentucky from human, environmental and poultry 
samples with a deca-resistant profile, ACKSSuSxTAmcCipNa in poultry [57, 58]. 
Salmonella Phages ES18, PDT17, DT104, DT120 and other P22-like prophages like 
ST104 or PDT17 haboured within DT104 have been proven to be participatory in 
the transduction and co-transduction of genes for ACSSuT resistance phenotype 
[33], making S. Kentucky ST198 a luxurious menu for the transduction of these 
genes complemented by other factors that may helps in phage-mediated trans-
duction of ARGs between serovars of Salmonella and other enterobacteriaceae. 
Several conjugative plasmids have also been detected in S. Kentucky ST198; IncA/C 
conjugative plasmids have been isolated in S. Kentucky ST198 that contain up to 10 
ARGs for more than five classes of antibiotics. The most common ARGs carried by 
IncA/C are strAB (aminoglycosides), sul2 (sulfonamides), tetAR (tetracycline), 
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blaCMY-2 (β-lactams), floR (chloramphenicols) and blaCTX-M-25 (cephalosporin). 
Other genes for resistance to aminoglycosides, tetracyclines, trimethoprim, chlor-
amphenicols, and have also been identified [49, 62–64]. S. Kentucky ST198 also 
contains an IncF plasmid [65]. IncF plasmids can carry multiple types of replicon 
associated genes, such as FIA, FII, or FIB [66]. IncF plasmids have been observed 
to contain ARGs, exhibiting resistance to fluoroquinolone [67], they have also 
been associated with strAB, tetA, tetC, tetD, aphA (aminoglycosides), and sul2 
(sulphonamides) resistance [68, 69]. Another plasmid of importance carried by 
S. Kentucky ST198 is the IncHI plasmid and has been associated with qnr genes 
(fluoroquinolones) and ESBL genes [70]. The integration of one of more of these 
conjugative plasmids that may be in close proximity to P22-like prophages would 
facilitate their packaging into the core of the assembling phage during induction 
from its host, thus contributing to the spread of antibiotic resistance between 
generic and non-generic bacteria in the intestinal flora of livestock and human and 
in the environment causing foodborne illnesses and outbreaks. Although the mode 
of acquisition of Plasmids ARGSs in Salmonella may seem random, their prolifera-
tion in a population is usually not random. Consequently, surveillance is a necessary 
tool, not just for Salmonella and other important human and animal pathogens, 
but for the plasmids they carry. Therefore, the tracking of plasmids and the genes 
they carry would allow for a better understanding of co-selection of ARGs and the 
associations of plasmids with Salmonella serotypes [71]. Finally since Salmonellae 
phages can bind to several protein receptors in Salmonellae and other members of 
the enterobacteriaceae family thereby permitting cross-serovar and inter-specie 
transduction of ARGs [43], it has become necessary that measures or protocols 
that can hinder such developments be adopted in order to forestall the spread of 
Salmonellae associated foodborne outbreaks.
8. Conclusion
The renewed and profound interest in phage therapy as a non-antibiotic mea-
sure for combating MDR strains of Salmonellae is a testament to their efficacy, 
but clearly Salmonella Kentucky ST198 posse’s virulent factors that can potentiate 
phage-mediated cross-serovar transduction and co-transduction of ARGs and 
MDR determinants, therefore investigative laboratory protocol should therefore be 
sought to identify these determinants prior to the institution of phages in the treat-
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